Codexis (CDXS) Other Non-Current Assets (2010 - 2026)
Codexis' (CDXS) quarterly Other Non-Current Assets came in at $425000.0 in Q1 2026, down 56.05% year-on-year from $967000.0 in Q1 2025, and down 11.09% quarter-over-quarter from $478000.0 in Q4 2025.
Codexis (CDXS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Codexis' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $425000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 56.05% year-over-year to $425000.0 in Q1 2026; TTM through Mar 2026 was $425000.0, a 56.05% decrease from a year earlier, with the FY2025 full-year figure at $478000.0, down 54.99% from the prior year.
- Other Non-Current Assets declined to $425000.0 in Q1 2026 per CDXS's latest filing, from $478000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.8 million in Q2 2024 and bottomed at $208000.0 in Q3 2022.
- The 5-year median for Other Non-Current Assets is $967000.0 (2025), against an average of $940705.9.
- Across the five-year window, Other Non-Current Assets sank 86.31% in 2022 and soared 410.58% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $521000.0 in 2022, then surged by 103.84% to $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024, then tumbled by 54.99% to $478000.0 in 2025, then declined by 11.09% to $425000.0 in 2026.
- Per Business Quant, the three latest CDXS Other Non-Current Assets figures stand at $425000.0 (Q1 2026), $478000.0 (Q4 2025), and $485000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | 425,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 478,000.00 |
| Sep 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Mar 31, 2025 | 967,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 514,000.00 |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 498,000.00 |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 521,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 579,000.00 |
| Sep 30, 2021 | 1.52 Mn |
| Jun 30, 2021 | 585,000.00 |